Literature DB >> 12419229

Transcription corepressor CtBP is an NAD(+)-regulated dehydrogenase.

Vivek Kumar1, Justin E Carlson, Kenneth A Ohgi, Thomas A Edwards, David W Rose, Carlos R Escalante, Michael G Rosenfeld, Aneel K Aggarwal.   

Abstract

Transcriptional repression is based on the selective actions of recruited corepressor complexes, including those with enzymatic activities. One well-characterized developmentally important corepressor is the C-terminal binding protein (CtBP). Although intriguingly related in sequence to D2 hydroxyacid dehydrogenases, the mechanism by which CtBP functions remains unclear. We report here biochemical and crystallographic studies which reveal that CtBP is a functional dehydrogenase. In addition, both a cofactor-dependent conformational change, with NAD(+) and NADH being equivalently effective, and the active site residues are linked to the binding of the PXDLS consensus recognition motif on repressors, such as E1A and RIP140. Together, our data suggest that CtBP is an NAD(+)-regulated component of critical complexes for specific repression events in cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12419229     DOI: 10.1016/s1097-2765(02)00650-0

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  111 in total

1.  The expanding network of redox signaling: new observations, complexities, and perspectives.

Authors:  Roy J Soberman
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

2.  CtBP/BARS: a dual-function protein involved in transcription co-repression and Golgi membrane fission.

Authors:  Marco Nardini; Stefania Spanò; Claudia Cericola; Alessandra Pesce; Anna Massaro; Enrico Millo; Alberto Luini; Daniela Corda; Martino Bolognesi
Journal:  EMBO J       Date:  2003-06-16       Impact factor: 11.598

3.  Functional similarity of Knirps CtBP-dependent and CtBP-independent transcriptional repressor activities.

Authors:  Jae-Ryeon Ryu; David N Arnosti
Journal:  Nucleic Acids Res       Date:  2003-08-01       Impact factor: 16.971

4.  CtBP contributes quantitatively to Knirps repression activity in an NAD binding-dependent manner.

Authors:  Montserrat Sutrias-Grau; David N Arnosti
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

5.  Nuclear receptor corepressor RIP140 regulates fat accumulation.

Authors:  Göran Leonardsson; Jenny H Steel; Mark Christian; Victoria Pocock; Stuart Milligan; Jimmy Bell; Po-Wah So; Gema Medina-Gomez; Antonio Vidal-Puig; Roger White; Malcolm G Parker
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-20       Impact factor: 11.205

6.  Conserved catalytic and C-terminal regulatory domains of the C-terminal binding protein corepressor fine-tune the transcriptional response in development.

Authors:  Yang W Zhang; David N Arnosti
Journal:  Mol Cell Biol       Date:  2010-11-15       Impact factor: 4.272

7.  CtBP1 interacts with Ikaros and modulates pituitary tumor cell survival and response to hypoxia.

Authors:  Katie Dorman; Zhongyi Shen; Caimei Yang; Shereen Ezzat; Sylvia L Asa
Journal:  Mol Endocrinol       Date:  2012-02-02

8.  A novel sensor of NADH/NAD+ redox poise in Streptomyces coelicolor A3(2).

Authors:  Dimitris Brekasis; Mark S B Paget
Journal:  EMBO J       Date:  2003-09-15       Impact factor: 11.598

9.  NAD+-dependent deacetylase Hst1p controls biosynthesis and cellular NAD+ levels in Saccharomyces cerevisiae.

Authors:  Antonio Bedalov; Maki Hirao; Jeffrey Posakony; Melisa Nelson; Julian A Simon
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

10.  Role of transcriptional corepressor CtBP1 in prostate cancer progression.

Authors:  Rui Wang; Irfan A Asangani; Balabhadrapatruni V S K Chakravarthi; Bushra Ateeq; Robert J Lonigro; Qi Cao; Ram-Shankar Mani; Daniel F Camacho; Natalie McGregor; Taibriana E W Schumann; Xiaojun Jing; Radhika Menawat; Scott A Tomlins; Heng Zheng; Arie P Otte; Rohit Mehra; Javed Siddiqui; Saravana M Dhanasekaran; Mukesh K Nyati; Kenneth J Pienta; Nallasivam Palanisamy; Lakshmi P Kunju; Mark A Rubin; Arul M Chinnaiyan; Sooryanarayana Varambally
Journal:  Neoplasia       Date:  2012-10       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.